Glutaredoxin and aging: how it affects cataracts and new treatment ideas
Official title: Novel Insights into Glutaredoxin's Role in Aging and Cataract: New Mechanisms and Therapies
Funded at University of North Texas Hlth Sci Ctr · NIH-11449438 · Data updated 2026-11-12
A research project explores how aging affects the lens of the eye and tests new ways to prevent or treat cataracts by studying antioxidant repair and inflammation.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of North Texas Hlth Sci Ctr NIH-funded |
| Lab location | 1 site (Fort Worth, United States) |
| Project start | September 4, 2026 |
| Project end | March 31, 2030 |
| Funding year | 2026 |
| Award (this year) | $410,514 |
| NIH project number | 1R01EY037721-01A1 |
| Project ID | NIH-11449438 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates are people at risk for or starting to experience age-related cataracts, or those interested in preventive eye health and future trials.
✕Less likely to help
People without age-related cataracts or those not eligible for research participation may not benefit.
What this research studies
This project investigates how aging changes the lens and contributes to cataracts, focusing on antioxidant repair systems and inflammatory pathways. Researchers use a special mouse model lacking Grx1 and Grx2 to see how these changes speed up cataract formation and signs of aging. The goal is to identify mechanisms that could be targeted with new therapies to protect the lens and potentially slow age-related vision loss. The work combines molecular studies of protein damage with timing-based experiments to find windows where interventions might be most effective.
Why it matters
Potential benefit: If successful, this work could lead to new treatments that protect the lens from age-related damage and reduce cataract risk.
How similar studies have gone: Prior studies show that antioxidant and inflammatory pathways influence lens aging, with some promising but early results in animal models.
Where this research is happening
-
University of North Texas Hlth Sci Ctr
Fort Worth, United States Active
Researchers
- Principal investigator: Wu, Hongli — University of North Texas Hlth Sci Ctr
- Study coordinator: Wu, Hongli
Related research
Other NIH-funded projects on the same topics.
-
Understanding how specific proteins in the eye lens interact with cell membranes as we age.
This study is looking at how a special protein called alphaA-crystallin interacts with lens cells in our eyes, especially as we age and develop cataracts, to help find ways to prevent or slow down cataract formation.
-
Aging Well with HIV: Alcohol, Risk Reduction, and Education Center (AWAR3E)
A center at Yale is exploring how aging with HIV interacts with alcohol use to create inflammation and frailty, with the goal of finding biomarkers and potential treatments.
-
Cognitive SuperAging: Exploring why some octogenarians stay sharp in memory
This NIH grant studies why a small group of people aged 80+ keep memory skills as good as much younger people, hoping to understand how to protect memory as we age.
-
Biological aging across the lifespan through a national high school-to-adult study
This grant uses a long-running national study of students and adults to collect saliva biomarkers of aging, alongside surveys, to understand how aging markers relate to health and life experiences.
-
Understanding how aging and Alzheimer’s affect how people make tough choices
This NIH grant studies how aging and Alzheimer’s risk change how people decide between immediate and delayed rewards and risky options, with the goal of helping older adults stay financially and healthwise safer.
-
Understanding how brain resilience and multiple brain pathologies influence aging and Alzheimer's disease
A long-term study follows older adults to learn how resilience to brain changes helps reduce dementia risk and what biological factors are linked to better cognitive aging.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.